Excerpt: The Committee on Energy and Commerce is investigating whether the Centers for Disease Control and Prevention (CDC) is complying with Federal safety requirements in its operation of the Emerging Infectious Diseases Laboratory, also known as CDC Building 18, a $214 million Biosafety Level 3 germ lab facility used for experiments involving anthrax, dangerous strains of influenza, the SARS
Excerpt: The Executive Order charges the Working Group to facilitate coordinated Administration Policy efforts to support safe and responsible unconventional natural gas development.’ However, the Executive Order flags augmenting State safeguards’ as a role for the Federal government.
Excerpt: We specifically seek EPA’s response concerning whether this reflects a reasonable estimate of the total present value cost of this regulation rule, based on EPA analysis and assumptions. We have continuing concerns about such an unprecedented, expensive rule with such far-reaching impacts across many states.
Excerpt: While Dr. Armendariz had previously advised Committee staff taht he would testify at the hearing, yesterday, the Committee was notified that he was declining to testify. In view of his decision not to testify, we request the following information and documents:
Excerpt: We understand that you plan to issue a proposed rule as soon as next week, a schedule that does not allow for full consideration of alternatives and review by expert scientists at other federal agencies. We therefore urge you to include the retention of the current standards in any proposed rule addressing the ambient air standards for particulate matter.
To read the letter to Department of Commerce Inspector General, click here.